Search

Your search keyword '"Testa A.C."' showing total 325 results
Start Over Author "Testa A.C."
325 results on '"Testa A.C."'

2. OC04.01: Prediction of non‐resectability in ovarian cancer patients using peritoneal cancer index: a prospective multicentre study using imaging (ISAAC study).

Author

Pinto, P., Moro, F., Chiappa, V., Testa, A.C., Franchi, D., Alcazar, J., Frühauf, F., Burgetova, A., Mašek, M., Lambert, L., Altmanova, D., Arraiza, M., Avesani, G., Panico, C., Alessi, S., Pricolo, P., Vigorito, R., Calareso, G., Kocian, R., and Slama, J.

Subjects
DIFFUSION magnetic resonance imaging, COMPUTED tomography, WHOLE body imaging, PERITONEAL cancer, CANCER patients, NEOADJUVANT chemotherapy
Abstract

This article presents the findings of a European multicentric observational cohort study that aimed to evaluate the performance of the peritoneal cancer index (PCI) using different imaging methods in assessing peritoneal carcinomatosis and predicting non-resectability in advanced tubo-ovarian cancer patients. The study compared the use of ultrasound, computed tomography (CT), and whole-body diffusion-weighted magnetic resonance imaging (WB-DWI/MRI) in calculating the PCI score. The results showed that ultrasound was non-inferior to CT in predicting non-resectability, and it was the best imaging method for determining preoperative PCI when performed by experienced examiners in dedicated oncological centers. [Extracted from the article]

Published
2024
Full Text
View/download PDF

5. EP23.71: That's huge! A case report of bilateral enlarged ovaries.

Author

Dababou, S., Pozzati, F., Russo, C., Testa, A.C., and Scambia, G.

Subjects
OVARIAN hyperstimulation syndrome, DILATATION & curettage, INSULIN resistance, OVARIES, POLYCYSTIC ovary syndrome, HYSTEROSCOPY
Abstract

This article presents a case report of a 35-year-old woman with bilateral enlarged ovaries. The patient had a history of polycystic ovary syndrome (PCOS) and had previously undergone surgeries for ovarian cysts. Despite the surgeries, her ovaries continued to enlarge due to her PCOS. The initial suspicion was spontaneous ovarian hyperstimulation syndrome (sOHSS), but further tests ruled out this diagnosis. The patient eventually underwent surgery to remove the cysts, and the histopathological examination confirmed the presence of serous cystadenofibromas. The article highlights the challenges in diagnosing bilateral cystadenofibromas and emphasizes the importance of thorough evaluation and clinical examination. [Extracted from the article]

Published
2024
Full Text
View/download PDF

6. EP23.09: Characterisation of ovarian masses using pelvic magnetic resonance imaging: the prospective IOTA‐MRI study.

Author

Vandecaveye, V., Kotlarz, A., Testa, A.C., Moro, F., Avesani, G., Van Pachterbeke, C., Hottat, N., Fischerová, D., Burgetova, A., Ebstain, E., Suzuki, C., Valentin, L., Jokubkiene, L., Bengtsson, J., Lieten, F., Verhoeven, I., Ceusters, J., Van Calster, B., Timmerman, D., and Froyman, W.

Subjects
MAGNETIC resonance imaging, RECEIVER operating characteristic curves, ADNEXAL diseases, ULTRASONIC imaging, LONGITUDINAL method
Abstract

This article discusses a study that aimed to evaluate the diagnostic accuracy of pelvic magnetic resonance imaging (MRI) in differentiating between benign and malignant adnexal masses. The study used the ADNEXMRSCORING system in cases where the IOTA Simple Rules (SR) were inconclusive. The results showed that pelvic MRI, combined with the ADNEXMRSCORING system, offers a promising second-line approach for diagnosing difficult adnexal masses. The findings suggest that this combined modality can improve diagnostic accuracy and guide appropriate management strategies for patients with these types of masses. [Extracted from the article]

Published
2024
Full Text
View/download PDF

7. EP22.48: Struma ovarii with foci of follicular variant of papillary thyroid carcinoma: a case report and ultrasound presentation.

Author

Zinicola, G., Ciccarone, F., Zoccoli, S. Gambigliani, Giudice, M., Scaglione, G., Zannoni, G., Testa, A.C., and Scambia, G.

Subjects
TRANSVAGINAL ultrasonography, IODINE isotopes, ABDOMINAL bloating, ABLATION techniques, PAPILLARY carcinoma, THYROID cancer
Abstract

This article discusses a case report of a rare tumor called struma ovarii (SO), which is characterized by the presence of thyroid tissue in the ovaries. Malignant transformation and metastasis of SO are rare, but when they occur, the most common subtypes are papillary and follicular thyroid carcinoma. The article presents the case of a 31-year-old patient with abdominal bloating, whose ultrasound examination revealed a solid mass in the right ovary. The patient underwent surgery, and the final histology report confirmed the presence of SO with foci of papillary thyroid carcinoma. The article emphasizes the importance of accurate preoperative diagnosis for appropriate treatment planning. [Extracted from the article]

Published
2024
Full Text
View/download PDF

8. EP22.39: Like gold dust: immature cystic teratoma – a case report.

Author

Dababou, S., Pozzati, F., Russo, C., Testa, A.C., and Scambia, G.

Subjects
OVARIAN tumors, EPIBLAST, ADJUVANT chemotherapy, TERATOMA, GERM cells, NEUROECTODERMAL tumors
Abstract

This article discusses a case report of a rare malignant ovarian tumor called immature cystic teratoma. The tumor is composed of three germ cell layers and is characterized by the presence of immature tissue. The ultrasound features of this tumor are not well-defined, but in this particular case, the tumor appeared as a large, unilateral, cystic-solid formation with irregular margins and a heterogeneous echostructure. The patient underwent comprehensive surgical management and received adjuvant chemotherapy. Further studies are needed to better understand the ultrasound features of immature cystic teratomas. [Extracted from the article]

Published
2024
Full Text
View/download PDF

9. OC05.03: *Deep learning‐enabled ovarian cancer detection with ADNEX‐AI: a prospective, multicentre study.

Author

Geysels, A., Garofalo, G., Timmerman, S., Ceusters, J., Fischerová, D., Testa, A.C., Moro, F., Buonomo, F., Valentin, L., Sladkevicius, P., Van Holsbeke, C., Kudla, M.J., Czekierdowski, A., Epstein, E., Groszmann, Y., Blaschko, M., De Moor, B., Van Calster, B., Timmerman, D., and Froyman, W.

Subjects
CONVOLUTIONAL neural networks, OVARIAN tumors, DEEP learning, RECEIVER operating characteristic curves, EARLY detection of cancer
Abstract

This article discusses a study that introduces a deep learning-based framework called ADNEX-AI for the automated detection of ovarian cancer using ultrasound scans. The study compares the performance of ADNEX-AI with traditional clinical practice in diagnosing ovarian cancer. The results show that ADNEX-AI achieves a high level of accuracy in distinguishing between benign and malignant ovarian tumors. However, the study suggests that the difference in performance between ADNEX-AI and traditional methods may be due to the clinician's ability to examine the tumor from different angles. Overall, ADNEX-AI demonstrates comparable performance to traditional methods when considering the constraints of tumor visibility. [Extracted from the article]

Published
2024
Full Text
View/download PDF

10. OC10.02: *Diagnostic performance of ultrasound in assessing the extension of disease in patients with advanced ovarian cancer: a prospective study

Author

Moruzzi, M.C., primary, Mascilini, F., additional, Bolomini, G., additional, Ficarelli, S., additional, Esposito, R., additional, Giudice, M., additional, Beneduce, G., additional, Moroni, R., additional, Scambia, G., additional, Fagotti, A., additional, Testa, A.C., additional, and Moro, F., additional

Published
2021
Full Text
View/download PDF

11. OC10.01: *Developing and validating ultrasound‐based radiomics models for predicting high‐risk category in endometrial cancer patients

Author

Moro, F., primary, Albanese, M., additional, Boldrini, L., additional, Chiappa, V., additional, Lenkowicz, J., additional, Bertolina, F., additional, Mascilini, F., additional, Moroni, R., additional, Gambacorta, M., additional, Raspagliesi, F., additional, Scambia, G., additional, Testa, A.C., additional, and Fanfani, F., additional

Published
2021
Full Text
View/download PDF

15. New approach for T-shaped uterus: Metroplasty with resection of lateral fibromuscular tissue using a 15 Fr miniresectoscope. A step-by-step technique.

Author

Catena, U., primary, Campo, R., additional, Bolomini, G., additional, Moruzzi, M.C., additional, Verdecchia, V., additional, Nardelli, F., additional, Romito, I., additional, Camolo, F., additional, La Manna, V., additional, Ianieri, M.M., additional, Scambia, G., additional, and Testa, A.C., additional

Published
2021
Full Text
View/download PDF

16. Validation of the performance of “Fast Lung Ultrasound Teaching Program” for gynecologists/obstetricians dealing with pregnant women with suspicion of COVID-19 infection: an Italian prospective multicenter study

Author

Moro, F., primary, Mascilini, F., additional, Buonsenso, D., additional, Inchingolo, R., additional, Smargiassi, A., additional, Soldati, G., additional, Copetti, R., additional, Demi, L., additional, Giorgini, P., additional, Moruzzi, M.C., additional, Ciccarone, F., additional, Moroni, R., additional, Frusca, T., additional, Scambia, G., additional, and Testa, A.C., additional

Published
2021
Full Text
View/download PDF

17. Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study

Author

Van Calster, B. Valentin, L. Froyman, W. Landolfo, C. Ceusters, J. Testa, A.C. Wynants, L. Sladkevicius, P. Van Holsbeke, C. Domali, E. Fruscio, R. Epstein, E. Franchi, D. Kudla, M.J. Chiappa, V. Alcazar, J.L. Leone, F.P.G. Buonomo, F. Coccia, M.E. Guerriero, S. Deo, N. Jokubkiene, L. Savelli, L. Fischerová, D. Czekierdowski, A. Kaijser, J. Coosemans, A. Scambia, G. Vergote, I. Bourne, T. Timmerman, D.

Abstract

OBJECTIVE: To evaluate the performance of diagnostic prediction models for ovarian malignancy in all patients with an ovarian mass managed surgically or conservatively. DESIGN: Multicentre cohort study. SETTING: 36 oncology referral centres (tertiary centres with a specific gynaecological oncology unit) or other types of centre. PARTICIPANTS: Consecutive adult patients presenting with an adnexal mass between January 2012 and March 2015 and managed by surgery or follow-up. MAIN OUTCOME MEASURES: Overall and centre specific discrimination, calibration, and clinical utility of six prediction models for ovarian malignancy (risk of malignancy index (RMI), logistic regression model 2 (LR2), simple rules, simple rules risk model (SRRisk), assessment of different neoplasias in the adnexa (ADNEX) with or without CA125). ADNEX allows the risk of malignancy to be subdivided into risks of a borderline, stage I primary, stage II-IV primary, or secondary metastatic malignancy. The outcome was based on histology if patients underwent surgery, or on results of clinical and ultrasound follow-up at 12 (±2) months. Multiple imputation was used when outcome based on follow-up was uncertain. RESULTS: The primary analysis included 17 centres that met strict quality criteria for surgical and follow-up data (5717 of all 8519 patients). 812 patients (14%) had a mass that was already in follow-up at study recruitment, therefore 4905 patients were included in the statistical analysis. The outcome was benign in 3441 (70%) patients and malignant in 978 (20%). Uncertain outcomes (486, 10%) were most often explained by limited follow-up information. The overall area under the receiver operating characteristic curve was highest for ADNEX with CA125 (0.94, 95% confidence interval 0.92 to 0.96), ADNEX without CA125 (0.94, 0.91 to 0.95) and SRRisk (0.94, 0.91 to 0.95), and lowest for RMI (0.89, 0.85 to 0.92). Calibration varied among centres for all models, however the ADNEX models and SRRisk were the best calibrated. Calibration of the estimated risks for the tumour subtypes was good for ADNEX irrespective of whether or not CA125 was included as a predictor. Overall clinical utility (net benefit) was highest for the ADNEX models and SRRisk, and lowest for RMI. For patients who received at least one follow-up scan (n=1958), overall area under the receiver operating characteristic curve ranged from 0.76 (95% confidence interval 0.66 to 0.84) for RMI to 0.89 (0.81 to 0.94) for ADNEX with CA125. CONCLUSIONS: Our study found the ADNEX models and SRRisk are the best models to distinguish between benign and malignant masses in all patients presenting with an adnexal mass, including those managed conservatively. TRIAL REGISTRATION: ClinicalTrials.gov NCT01698632. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.

Published
2020

18. Ovine congenital progressive muscular dystrophy (OCPMD) is a model of TNNT1 congenital myopathy

Author

Clayton, J.S., McNamara, E.L., Goullee, H., Conijn, S., Muthsam, K., Musk, G.C., Coote, D., Kijas, J., Testa, A.C., Taylor, R.L., O’Hara, A.J., Groth, D., Ottenheijm, C., Ravenscroft, G., Laing, N.G., Nowak, K.J., Clayton, J.S., McNamara, E.L., Goullee, H., Conijn, S., Muthsam, K., Musk, G.C., Coote, D., Kijas, J., Testa, A.C., Taylor, R.L., O’Hara, A.J., Groth, D., Ottenheijm, C., Ravenscroft, G., Laing, N.G., and Nowak, K.J.

Abstract

Ovine congenital progressive muscular dystrophy (OCPMD) was first described in Merino sheep flocks in Queensland and Western Australia in the 1960s and 1970s. The most prominent feature of the disease is a distinctive gait with stiffness of the hind limbs that can be seen as early as 3 weeks after birth. The disease is progressive. Histopathological examination had revealed dystrophic changes specifically in type I (slow) myofibres, while electron microscopy had demonstrated abundant nemaline bodies. Therefore, it was never certain whether the disease was a dystrophy or a congenital myopathy with dystrophic features. In this study, we performed whole genome sequencing of OCPMD sheep and identified a single base deletion at the splice donor site (+ 1) of intron 13 in the type I myofibre-specific TNNT1 gene (KT218690 c.614 + 1delG). All affected sheep were homozygous for this variant. Examination of TNNT1 splicing by RT-PCR showed intron retention and premature termination, which disrupts the highly conserved 14 amino acid C-terminus. The variant did not reduce TNNT1 protein levels or affect its localization but impaired its ability to modulate muscle contraction in response to Ca2+ levels. Identification of the causative variant in TNNT1 finally clarifies that the OCPMD sheep is in fact a large animal model of TNNT1 congenital myopathy. This model could now be used for testing molecular or gene therapies.

Published
2020

19. OC06.03: Terms, definitions and measurements to describe the sonographic features of lymph nodes: a consensus opinion from the Vulvar International Tumor Analysis (VITA) group

Author

Fischerová, D., primary, Reina, H., additional, Garganese, G., additional, Fragomeni, S., additional, Frühauf, F., additional, Testa, A.C., additional, Epstein, E., additional, Valentin, L., additional, Guiggi, I., additional, Nanka, O., additional, Rettenbacher, T., additional, Heinzelmann‐Schwarz, V., additional, Scambia, G., additional, and Cibula, D., additional

Published
2020
Full Text
View/download PDF

21. VP66.11: Clinical and ultrasound characteristics of ovarian carcinosarcomas

Author

Ciccarone, F., primary, Biscione, A., additional, Codecà, C., additional, Ettore, C., additional, Fischerová, D., additional, Savelli, L., additional, Valentin, L., additional, Fruscio, R., additional, Chiappa, V., additional, Franchi, D., additional, Timmerman, D., additional, Sladkevicius, P., additional, Jokubkiene, L., additional, Froyman, W., additional, Scambia, G., additional, and Testa, A.C., additional

Published
2020
Full Text
View/download PDF

23. VP66.26: Diagnostic performance of ultrasound in assessing the abdominal spread of advanced ovarian cancer and correlation to Fagotti score: a prospective study

Author

Moruzzi, M., primary, Bolomini, G., additional, Moro, F., additional, Mascilini, F., additional, Quagliozzi, L., additional, Ficarelli, S., additional, Giudice, M., additional, Beneduce, G., additional, Taccaliti, C., additional, Scambia, G., additional, Fagotti, A., additional, and Testa, A.C., additional

Published
2020
Full Text
View/download PDF

26. OC03.01: *A comparison between the IOTA assessment of different neoplasias in the adnexa, the risk of malignancy index and the risk of ovarian malignancy algorithm to assess the risk of malignancy in women with an ovarian tumour

Author

Landolfo, C., primary, Ceusters, J., additional, Coosemans, A., additional, Van Gorp, T., additional, Froyman, W., additional, Heremans, R., additional, Thirion, G., additional, Oosterlynck, J., additional, Van Rompay, A., additional, Vergote, I., additional, Testa, A.C., additional, Valentin, L., additional, Billen, J., additional, Bourne, T., additional, Van Calster, B., additional, and Timmerman, D., additional

Published
2020
Full Text
View/download PDF

28. OC06.01: *Comparison of pre‐ and postmenopausal endometrial cancer regarding sonographic features and clinical characteristics: results from the IETA‐4 cohort

Author

Green, R.W., primary, Fischerová, D., additional, Testa, A.C., additional, Franchi, D., additional, Frühauf, F., additional, Lindqvist, P.G., additional, Di Legge, A., additional, Cibula, D., additional, Fruscio, R., additional, Haak, L.A., additional, Opolskiene, G., additional, Urbinati, A.M. Vidal, additional, Timmerman, D., additional, Bourne, T., additional, Van den Bosch, T., additional, and Epstein, E., additional

Published
2020
Full Text
View/download PDF

30. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study

Author

Froyman, W. Landolfo, C. De Cock, B. Wynants, L. Sladkevicius, P. Testa, A.C. Van Holsbeke, C. Domali, E. Fruscio, R. Epstein, E. dos Santos Bernardo, M.J. Franchi, D. Kudla, M.J. Chiappa, V. Alcazar, J.L. Leone, F.P.G. Buonomo, F. Hochberg, L. Coccia, M.E. Guerriero, S. Deo, N. Jokubkiene, L. Kaijser, J. Coosemans, A. Vergote, I. Verbakel, J.Y. Bourne, T. Van Calster, B. Valentin, L. Timmerman, D.

Abstract

Background: Ovarian tumours are usually surgically removed because of the presumed risk of complications. Few large prospective studies on long-term follow-up of adnexal masses exist. We aimed to estimate the cumulative incidence of cyst complications and malignancy during the first 2 years of follow-up after adnexal masses have been classified as benign by use of ultrasonography. Methods: In the international, prospective, cohort International Ovarian Tumor Analysis Phase 5 (IOTA5) study, patients aged 18 years or older with at least one adnexal mass who had been selected for surgery or conservative management after ultrasound assessment were recruited consecutively from 36 cancer and non-cancer centres in 14 countries. Follow-up of patients managed conservatively is ongoing at present. In this 2-year interim analysis, we analysed patients who were selected for conservative management of an adnexal mass judged to be benign on ultrasound on the basis of subjective assessment of ultrasound images. Conservative management included ultrasound and clinical follow-up at intervals of 3 months and 6 months, and then every 12 months thereafter. The main outcomes of this 2-year interim analysis were cumulative incidence of spontaneous resolution of the mass, torsion or cyst rupture, or borderline or invasive malignancy confirmed surgically in patients with a newly diagnosed adnexal mass. IOTA5 is registered with ClinicalTrials.gov, number NCT01698632, and the central Ethics Committee and the Belgian Federal Agency for Medicines and Health Products, number S51375/B32220095331, and is ongoing. Findings: Between Jan 1, 2012, and March 1, 2015, 8519 patients were recruited to IOTA5. 3144 (37%) patients selected for conservative management were eligible for inclusion in our analysis, of whom 221 (7%) had no follow-up data and 336 (11%) were operated on before a planned follow-up scan was done. Of 2587 (82%) patients with follow-up data, 668 (26%) had a mass that was already in follow-up at recruitment, and 1919 (74%) presented with a new mass at recruitment (ie, not already in follow-up in the centre before recruitment). Median follow-up of patients with new masses was 27 months (IQR 14–38). The cumulative incidence of spontaneous resolution within 2 years of follow-up among those with a new mass at recruitment (n=1919) was 20·2% (95% CI 18·4–22·1), and of finding invasive malignancy at surgery was 0·4% (95% CI 0·1–0·6), 0·3% (

Published
2019

31. OC01.04: Incidental finding of endometrial cancer: results from a multicentre prospective cohort study (IETA3)

Author

Heremans, R., primary, Van den Bosch, T., additional, Pascual, M., additional, Fruscio, R., additional, Testa, A.C., additional, Mascilini, F., additional, Moro, F., additional, Buonomo, F., additional, Guerriero, S., additional, Rossi, A., additional, Domali, E., additional, Zlotorowicz‐Grochowska, R., additional, Kudla, M.J., additional, Szajnik, M., additional, Van Holsbeke, C., additional, Fischerová, D., additional, Froyman, W., additional, Epstein, E., additional, Valentin, L., additional, Bourne, T., additional, Timmerman, D., additional, and Leone, F., additional

Published
2019
Full Text
View/download PDF

34. OC08.05: Incidental finding of endometrial polyps: results from a prospective multicentre study (IETA3)

Author

Heremans, R., primary, Van den Bosch, T., additional, Pascual, M., additional, Fruscio, R., additional, Testa, A.C., additional, Mascilini, F., additional, Moro, F., additional, Buonomo, F., additional, Guerriero, S., additional, Rossi, A., additional, Domali, E., additional, Zlotorowicz‐Grochowska, R., additional, Kudla, M.J., additional, Szajnik, M., additional, Van Holsbeke, C., additional, Fischerová, D., additional, Froyman, W., additional, Epstein, E., additional, Valentin, L., additional, Bourne, T., additional, Timmerman, D., additional, and Leone, F., additional

Published
2019
Full Text
View/download PDF

36. EP34.02: Clinical and ultrasound features of extra gastrointestinal stromal tumours (eGIST)

Author

Fischerová, D., primary, Ambrosio, M., additional, Testa, A.C., additional, Moro, F., additional, Franchi, D., additional, Scifo, M., additional, Rams, N., additional, Epstein, E., additional, Alcazar, J., additional, Hidalgo, J., additional, Van Holsbeke, C., additional, Timmerman, D., additional, Burgetova, A., additional, Dundr, P., additional, and Cibula, D., additional

Published
2019
Full Text
View/download PDF

37. OP03.04: Imaging in gynecological disease: ultrasound features of malignant yolk sac tumours (endodermal sinus tumours)

Author

Anfelter, P., primary, Testa, A.C., additional, Chiappa, V., additional, Froyman, W., additional, Fruscio, R., additional, Guerriero, S., additional, Mascilini, F., additional, Pascual, M., additional, Sibal, M., additional, Savelli, L., additional, Alcazar, J., additional, Zannoni, G., additional, Timmerman, D., additional, and Epstein, E., additional

Published
2019
Full Text
View/download PDF

38. OC24.05: Clinical and ultrasound characteristics of adnexal torsion

Author

Moro, F., primary, Bolomini, G., additional, Boopathy, V., additional, Priti, V., additional, Jurkovic, D., additional, Pasciuto, T., additional, Mascilini, F., additional, Pozzati, F., additional, Leone, F., additional, Epstein, E., additional, Guerriero, S., additional, Scambia, G., additional, Sibal, M., additional, Valentin, L., additional, and Testa, A.C., additional

Published
2019
Full Text
View/download PDF

42. OP03.08: Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses

Author

Moro, F., primary, Pasciuto, T., additional, Djokovic, D., additional, Di Legge, A., additional, Granato, V., additional, Moruzzi, M., additional, Mancari, R., additional, Mascilini, F., additional, Zannoni, G., additional, Fischerová, D., additional, Franchi, D., additional, Scambia, G., additional, and Testa, A.C., additional

Published
2018
Full Text
View/download PDF

43. OC08.08: Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria

Author

Eriksson, L., primary, Nastic, D., additional, Fruhauf, F., additional, Fischerová, D., additional, Nemejcova, K., additional, Bono, F., additional, Franchi, D., additional, Fruscio, R., additional, Ghioni, M., additional, Haak, L.A., additional, Hejda, V., additional, Meskauskas, R., additional, Opolskiene, G., additional, Pascual, M., additional, Tresserra, F., additional, Testa, A.C., additional, Zannoni, G., additional, Carlson, J., additional, and Epstein, E., additional

Published
2018
Full Text
View/download PDF

44. OC08.02: A preoperative risk model with ultrasound variables to assess lymph node metastasis in endometrial cancer patients: a model development and validation study by the IETA group

Author

Eriksson, L., primary, Epstein, E., additional, Testa, A.C., additional, Fischerová, D., additional, Valentin, L., additional, Franchi, D., additional, Fruhauf, F., additional, Fruscio, R., additional, Haak, L.A., additional, Opolskiene, G., additional, Mascilini, F., additional, Alcazar, J., additional, Van Holsbeke, C., additional, Chiappa, V., additional, Bourne, T., additional, Lindqvist, P.G., additional, Van Calster, B., additional, Installé, A., additional, Timmerman, D., additional, Verbakel, J.Y., additional, Van den Bosch, T., additional, and Wynants, L., additional

Published
2018
Full Text
View/download PDF

46. OC08.03: Subjective and objective strategies to assess myometrial invasion and cervical stromal invasion in women with endometrial cancer from the IETA cohort

Author

Verbakel, J.Y., primary, Mascilini, F., additional, Fischerová, D., additional, Testa, A.C., additional, Franchi, D., additional, Vidal Urbinati, A., additional, Valentin, L., additional, Fruhauf, F., additional, Cibula, D., additional, Lindqvist, P.G., additional, Fruscio, R., additional, Haak, L.A., additional, Opolskiene, G., additional, Alcazar, J., additional, Mais, V., additional, Carlson, J., additional, Sladkevicius, P., additional, Installé, A., additional, Wynants, L., additional, Van den Bosch, T., additional, Timmerman, D., additional, and Epstein, E., additional

Published
2018
Full Text
View/download PDF

47. OC12.06: Validation of objective measurements to predict myometrial or cervical stromal invasion and prediction models to predict high-risk endometrial cancer

Author

Verbakel, J.Y., primary, Mascilini, F., additional, Fischerová, D., additional, Testa, A.C., additional, Franchi, D., additional, Valentin, L., additional, Fruhauf, F., additional, Cibula, D., additional, Lindqvist, P.G., additional, Fruscio, R., additional, Haak, L.A., additional, Opolskiene, G., additional, Alcazar, J., additional, Mais, V., additional, Carlson, J., additional, Sladkevicius, P., additional, Wynants, L., additional, Van den Bosch, T., additional, Timmerman, D., additional, and Epstein, E., additional

Published
2018
Full Text
View/download PDF

48. OC01.02: Balancing risks of surgery with risks of conservative management of benign adnexal masses: results from the postmenopausal follow-up arm of IOTA5

Author

Froyman, W., primary, Landolfo, C., additional, De Cock, B., additional, Wynants, L., additional, Valentin, L., additional, Sladkevicius, P., additional, Testa, A.C., additional, Van Holsbeke, C., additional, Bernardo, M., additional, Epstein, E., additional, Domali, E., additional, Leone, F., additional, Franchi, D., additional, Buonomo, F., additional, Fruscio, R., additional, Coccia, M., additional, Hochberg, L., additional, Chiappa, V., additional, Alcazar, J., additional, Kudla, M.J., additional, Guerriero, S., additional, Verbakel, J.Y., additional, Bourne, T., additional, Van Calster, B., additional, and Timmerman, D., additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results